Poster + Presentation
7 March 2022 Ophthalmic laser platform utilizing AI to enhance treatment planning of liposomal drug release
Author Affiliations +
Proceedings Volume PC11941, Ophthalmic Technologies XXXII; PC119411F (2022)
Event: SPIE BiOS, 2022, San Francisco, California, United States
Conference Poster
Delivery of pharmaceuticals to the eye posterior poses a major challenge in ophthalmology. A promising drug delivery platform is indocyanine green (ICG) liposomes, which absorb near-infrared light resulting in a release of pharmaceutical molecules. The Modulight ophthalmic laser platform has been designed for treatments targeting the eye posterior and can also excite the absorption band of the liposomes. The laser connects with Modulight Cloud, enabling artificial intelligence (AI) based treatment planning by correlating the treatment parameters and success, which could increase the efficacy of future treatments. The same algorithms could deduce which treatment parameters work with which liposomal delivery parameters.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Eero Koivumäki, Laura Vesala, Jukka-Pekka Alanko, Timo Tanila, and Petteri Uusimaa "Ophthalmic laser platform utilizing AI to enhance treatment planning of liposomal drug release", Proc. SPIE PC11941, Ophthalmic Technologies XXXII, PC119411F (7 March 2022);
Get copyright permission  Get copyright permission on Copyright Marketplace
Artificial intelligence


Laser applications


Evolutionary algorithms

Laser therapeutics

Machine learning

Back to Top